10.05.20

Sun Ophthalmics to Present E-Posters at AAOpt

Source: Sun Ophthalmics

09.29.20

Ocular Therapeutix Announces First Patients Dosed in Phase 2 Clinical Trial of OTX-CSI for the Treatment of Dry Eye Disease

Source: Ocular Therapeutix

09.09.20

Sight Sciences Presents Additional Results of OLYMPIA Study of Signs and Symptoms of Dry Eye Disease Using TearCare

Source: Sight Sciences

08.24.20

Neuroptika Completes Enrollment In Phase 2 Clinical Trial For Dry Eye Disease

Source: Neuroptika

08.05.20

Palatin Technologies Completes Enrollment of Phase 2 Study for Dry Eye Disease Treatment Candidate

Source: Palatin Technologies

07.24.20

Novartis Launches “Not Today, Dry Eye” Consumer Campaign

Source: Novartis

07.08.20

Palatin Technologies Announces Reinitiation of Enrollment of Phase 2 Study With PL9643 for the Treatment of Dry Eye Disease

Source: Palatin Technologies

06.04.20

Aldeyra Therapeutics Reaches Agreement With FDA for Use of RASP as Dry Eye Disease Sign

Source: Aldeyra Therapeutics, Inc.

05.28.20

New Alcon Program Aims to Help ECPs Tap Into Opportunities in the Dry Eye Market Amid COVID-19 Crisis

Source: Alcon

05.26.20

Kala Pharmaceuticals Files New Drug Application to FDA for Eysuvis for Dry Eye Disease

Source: Kala Pharmaceuticals

View more stories